Mark Mossler

Insider Reports History

Location
Watertown, MA
Signature
/s/ Shagha Russell, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mark Mossler:

Company Role Class Num Shares Value Price $ Report Date Ownership
C4 Therapeutics, Inc. Chief Accounting Officer Common Stock 18,204 $57,889 $3.18 14 Feb 2025 Direct
C4 Therapeutics, Inc. Chief Accounting Officer Stock Option (Right to Buy) 27,430 14 Feb 2024 Direct

Insider Reports Filed by Mark Mossler

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CCCC C4 Therapeutics, Inc. 14 Feb 2025 1 -$5,043 4 Chief Accounting Officer 18 Feb 2025, 16:55
CCCC C4 Therapeutics, Inc. 14 Feb 2024 2 $0 4 Chief Accounting Officer 10 Apr 2024, 16:16
CCCC C4 Therapeutics, Inc. 18 Sep 2023 0 $0 3 Chief Accounting Officer 19 Sep 2023, 20:20